Covid-19 resource center

EANcore COVID-19

As the CoVID-19 pandemic spreads across Europe and the world, in response EAN has launched EANcore CoVID-19 to help neurologists in Europe and beyond prepare for and manage the challenges this global crisis is bringing.

EAN membership

Become an EAN member today

Access to all congress webcasts, full online version of the European Journal of Neurology and EAN Guideline Reference Center, apply for educational grants and many more...

6th EAN Congress 2020 Goes Virtual

Dear neurologists, other healthcare professionals, and neuroscientists,

Dear colleagues and friends

In the interest of the health, safety and well-being of all registered attendees, our patients and families, as well as the general public, the European Academy of Neurology (EAN) has decided to cancel all in-person attendance and face-to-face activities at the Annual Congress, of May 23-26, 2020 in Paris. This decision has been taken due to the COVID-19 Coronavirus pandemic and in full support of public authorities in Europe and the World in their effort to slow the spread of the disease.

Difficult times ask for creative and courageous solutions which may also open new avenues for a better future. We must stay positive, strong and united more than ever to come through this crisis. Accordingly, the EAN Board has decided to organize the 6th EAN Congress as Virtual Congress for May 23-26, 2020 and offer to the neurology community the possibility for education, scientific news and best practice exchange without leaving home.

The Corona pandemic is putting our society under an incredible health, emotional and economic burden. EAN has decided, with its industry partners, to make its contribution to mitigate the consequences of the pandemic in offering the on-line participation to the EAN Virtual Congress free-of-charge.

All sessions will be available on-demand for EAN members from 27 May onwards. If you have already registered for the EAN Paris 2020 Congress, your fees will be refunded.  

Details regarding the EAN Virtual Congress and registration will be announced in due course. Please do also visit our Frequently Asked Questions area.

Best wishes for good health to you, your families and your community.

Truly yours,

Claudio L. Bassetti

EAN Acting President

European Academy of Neurology

Our mission is to promote neurological excellence in Europe and across the world, leading to better patient care and outcomes. We unite 47 national societies and represent more than 45,000 neurologists to achieve this goal.

Find out more.

NEuro-covid ReGistrY (ENERGY)

please click here to join the registry

  1. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy

  2. Brain MRI Findings in Patients in the Intensive Care Unit with COVID-19 Infection

  3. Lessons of the month 1: A case of rhombencephalitis as a rare complication of acute COVID-19 infection

  4. Dealing with immune-mediated neuropathies during COVID-19 outbreak: practical recommendations from the task force of the Italian Society of Neurology (SIN), the Italian Society of Clinical Neurophysiology (SINC) and the Italian Peripheral Nervous System Association (ASNP)

  5. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network

  6. Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV Gliomas

  7. Recommendations for Deep Brain Stimulation Device Management During a Pandemic

  8. COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient Care

  9. An Italian programme for COVID-19 infection in multiple sclerosis

  10. COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach

  11. COVID-19 infection in a patient with multiple sclerosis treated with fingolimod

  12. Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

  13. Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

  14. Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

  15. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia

  16. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study

  17. Interpreting Diagnostic Tests for SARS-CoV-2


I believe that the covid-19 pandemic showed us that we, as neurologists, are physicians first, and neurologists second. In other words, as neurology has increasingly developed into an acute care field, it is important that we are not only specialists in neurology, but also strive to build and keep expertise in fields adjacent to our core competences. 

CME Articles
European Journal of Neurology

May Issue available now

Edited by: Didier Leys
Deputy Editor: Claudia Sommer; Associate Editors: Andrew Chan, Mark Edwards, Kristl Vonck
Impact factor: 4.387

6th EAN congress

Scientific Programme

Discover the Scientific Programme of the 6th EAN Congress!

EAN 2020

Thank you!

Almost 20 000 Participants!
Join us at the EAN Virtual Congress - Free of Charge

| COVID-19

Rare neurological diseases are usually hereditary chronic disorders, affecting the central, peripheral nervous system and skeletal muscle, with…

| COVID-19

This neurology update summarises key points on caring for people with epilepsy during the COVID-19 pandemic.

| COVID-19

Seizures appear to be a rare feature of COVID-19. Avoiding unintentional antiseizure medicine withdrawal during the COVID-19 pandemic is a potential…